ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeNo recent work listed
Ge Chen
Matched on ORCID iD 0000-0003-1758-747X; OpenAlex author ID A5003898324. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2011: 1 paper · 2012: 2 papers · 2013: 3 papers · 2014: 1 paper · 2015: none · 2016: 1 paper
Papers 8
- c-Fos/ERK promotes the progression from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/or.2016.5169↗
- Alteration of the intrinsic apoptosis pathway is involved in Notch-induced chemoresistance to gemcitabine in pancreatic cancer. Co-author DOI 10.1016/j.arcmed.2013.10.001↗
- Notch1 contributes to chemoresistance to gemcitabine and serves as an unfavorable prognostic indicator in pancreatic cancer. Co-author DOI 10.1007/s00268-013-2010-0↗
- Therapy of Smac mimetic SM-164 in combination with gemcitabine for pancreatic cancer. Co-author DOI 10.1016/j.canlet.2012.10.039↗
- [Expression of eukaryotic translation initiation factor 5A2 in pancreatic adenocarcinoma and its correlation with the prognosis]. First author DOI 10.3881/j.issn.1000-503x.2013.06.009↗
- NOP14 promotes proliferation and metastasis of pancreatic cancer cells. Co-author DOI 10.1016/j.canlet.2012.03.010↗
- Induction, modulation and potential targets of miR-210 in pancreatic cancer cells. Co-author DOI 10.1016/s1499-3872(12)60168-4↗
- Bcl-2 upregulation induced by miR-21 via a direct interaction is associated with apoptosis and chemoresistance in MIA PaCa-2 pancreatic cancer cells. Last author DOI 10.1016/j.arcmed.2011.01.006↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yu-Pei Zhao · 7 shared papers, 2011–2014 · strength 0.28
- Paper [Expression of eukaryotic translation initiation factor 5A2 in pancreatic adenocarcinoma and its correlation with the p… DOI 10.3881/j.issn.1000-503x.2013.06.009↗
- Paper Alteration of the intrinsic apoptosis pathway is involved in Notch-induced chemoresistance to gemcitabine in pancreatic… DOI 10.1016/j.arcmed.2013.10.001↗
- Paper Therapy of Smac mimetic SM-164 in combination with gemcitabine for pancreatic cancer. DOI 10.1016/j.canlet.2012.10.039↗
- Lei You · 5 shared papers, 2013–2016 · strength 0.24
- Paper c-Fos/ERK promotes the progression from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma. DOI 10.3892/or.2016.5169↗
- Paper [Expression of eukaryotic translation initiation factor 5A2 in pancreatic adenocarcinoma and its correlation with the p… DOI 10.3881/j.issn.1000-503x.2013.06.009↗
- Paper Alteration of the intrinsic apoptosis pathway is involved in Notch-induced chemoresistance to gemcitabine in pancreatic… DOI 10.1016/j.arcmed.2013.10.001↗
- Taiping Zhang · 5 shared papers, 2011–2014 · strength 0.20
- Paper Alteration of the intrinsic apoptosis pathway is involved in Notch-induced chemoresistance to gemcitabine in pancreatic… DOI 10.1016/j.arcmed.2013.10.001↗
- Paper Therapy of Smac mimetic SM-164 in combination with gemcitabine for pancreatic cancer. DOI 10.1016/j.canlet.2012.10.039↗
- Paper NOP14 promotes proliferation and metastasis of pancreatic cancer cells. DOI 10.1016/j.canlet.2012.03.010↗
- Li Zhou · 4 shared papers, 2011–2014 · strength 0.15
- Paper Alteration of the intrinsic apoptosis pathway is involved in Notch-induced chemoresistance to gemcitabine in pancreatic… DOI 10.1016/j.arcmed.2013.10.001↗
- Paper Notch1 contributes to chemoresistance to gemcitabine and serves as an unfavorable prognostic indicator in pancreatic ca… DOI 10.1007/s00268-013-2010-0↗
- Paper Induction, modulation and potential targets of miR-210 in pancreatic cancer cells. DOI 10.1016/s1499-3872(12)60168-4↗
- Hong Shu · 3 shared papers, 2012–2014 · strength 0.11
- Paper Alteration of the intrinsic apoptosis pathway is involved in Notch-induced chemoresistance to gemcitabine in pancreatic… DOI 10.1016/j.arcmed.2013.10.001↗
- Paper Notch1 contributes to chemoresistance to gemcitabine and serves as an unfavorable prognostic indicator in pancreatic ca… DOI 10.1007/s00268-013-2010-0↗
- Paper Induction, modulation and potential targets of miR-210 in pancreatic cancer cells. DOI 10.1016/s1499-3872(12)60168-4↗
- Bin Zhou · 2 shared papers, 2012–2013 · strength 0.08
- Xiao Hong Du · 2 shared papers, 2013–2014 · strength 0.08
- Paper Alteration of the intrinsic apoptosis pathway is involved in Notch-induced chemoresistance to gemcitabine in pancreatic… DOI 10.1016/j.arcmed.2013.10.001↗
- Paper Notch1 contributes to chemoresistance to gemcitabine and serves as an unfavorable prognostic indicator in pancreatic ca… DOI 10.1007/s00268-013-2010-0↗
- Tianxiao Wang · 2 shared papers, 2013–2014 · strength 0.08
- Paper Alteration of the intrinsic apoptosis pathway is involved in Notch-induced chemoresistance to gemcitabine in pancreatic… DOI 10.1016/j.arcmed.2013.10.001↗
- Paper Notch1 contributes to chemoresistance to gemcitabine and serves as an unfavorable prognostic indicator in pancreatic ca… DOI 10.1007/s00268-013-2010-0↗
- Ming Cui · 1 shared paper, 2016 · strength 0.07
- Yongxing Du · 1 shared paper, 2016 · strength 0.07
- Xiaoxia Ren · 1 shared paper, 2016 · strength 0.07
- Yupei Zhao · 1 shared paper, 2016 · strength 0.07
- Yingxin Wei · 1 shared paper, 2013 · strength 0.05
- Jie Zhang · 1 shared paper, 2013 · strength 0.04
- Weiyun Chen · 1 shared paper, 2012 · strength 0.03
- Jie Dong · 1 shared paper, 2011 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.